WELL Health Technologies Corp. (WELL.TO)
| Previous close | 3.8200 |
| Open | 3.8400 |
| Bid | 3.8200 x N/A |
| Ask | 3.8400 x N/A |
| Day's range | 3.8100 - 3.8700 |
| 52-week range | 3.4100 - 5.5500 |
| Volume | |
| Avg. volume | 995,659 |
| Market cap | 943.724M |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | ∞ |
| EPS (TTM) | 0.0000 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.39 |
GlobeNewswireHEALWELL AI Reports Q1-2024 Financial Results
HEALWELL AI achieved quarterly revenue from continuing operations of $4.58 million in Q1-2024, 132% higher compared to $1.97 million generated in Q1-2023 and 139% higher than $1.92 million generated in Q4-2023.Since its relaunch in Q4-2023 and its acquisition of Intrahealth, an enterprise class EHR service provider on February 1, 2024, the Company’s annual revenue run rate has more than doubled to over $20 million with the largest component of revenues now coming from SaaS and services.Managemen
Simply Wall St.WELL Health Technologies First Quarter 2024 Earnings: Beats Expectations
WELL Health Technologies ( TSE:WELL ) First Quarter 2024 Results Key Financial Results Revenue: CA$231.6m (up 37% from...
PR NewswireWELL Health Reports Record Quarterly Revenue and Record Net Income for a first quarter in Q1-2024 and Increases Both Revenue and Adjusted EBITDA Guidance for 2024
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its interim consolidated financial results for the quarter ended March 31, 2024.
